Wang J - Search Results

1

Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.

Liu F, Meng Z, Shao G, Wang J, Wang Z, Yang J, Yip CS, He D. Liu F, et al. Among authors: wang j, wang z. Mol Biol Rep. 2017 Feb;44(1):149-158. doi: 10.1007/s11033-016-4092-x. Epub 2016 Dec 15. Mol Biol Rep. 2017. PMID: 27981445

2

[Intratumoral microvessel density and expression of vascular endothelial growth factor in hepatocellular carcinoma after chemoembolization].

Shao G, Wang J, Zhou K, Yan Z. Shao G, et al. Among authors: wang j. Zhonghua Gan Zang Bing Za Zhi. 2002 Jun;10(3):170-3. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12113668 Chinese.

3

Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.

Yan FH, Zhou KR, Cheng JM, Wang JH, Yan ZP, Da RR, Fan J, Ji Y. Yan FH, et al. Among authors: wang jh. World J Gastroenterol. 2002 Aug;8(4):658-62. doi: 10.3748/wjg.v8.i4.658. World J Gastroenterol. 2002. PMID: 12174374 Free PMC article.

4

A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma.

Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Yu Y, Wang JH, Guo W. Zeng ZC, et al. Among authors: wang jh, wang bl. Cancer J. 2004 Sep-Oct;10(5):307-16. doi: 10.1097/00130404-200409000-00008. Cancer J. 2004. PMID: 15530260

5

A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.

Zeng ZC, Fan J, Tang ZY, Zhou J, Qin LX, Wang JH, Sun HC, Wang BL, Zhang JY, Jiang GL, Wang YQ. Zeng ZC, et al. Among authors: wang jh, wang yq, wang bl. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):432-43. doi: 10.1016/j.ijrobp.2004.05.025. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667964

6

[Interventional therapy for hepatocellular carcinoma].

Wang JH. Wang JH. Zhonghua Gan Zang Bing Za Zhi. 2005 Oct;13(10):721-3. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16248940 Chinese. No abstract available.

7

[Transhepatic arterial chemoembolization by epirubicin mixed with microspheres for hepatocellular carcinoma].

Luo JJ, Yan ZP, Wang JH, Liu QX, Chen Y. Luo JJ, et al. Zhonghua Zhong Liu Za Zhi. 2007 Aug;29(8):619-22. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18210885 Chinese.

8

Identifying serum biomarkers for TACE therapy efficiency of hepatocellular carcinoma.

Li CY, Wang XL, Wang JH, Yan ZP, Gong GQ, Cheng JM, Chen Y, Liu LX, Li GP, Wang CG, Shi DH. Li CY, et al. Front Biosci (Elite Ed). 2011 Jan 1;3(1):212-20. doi: 10.2741/e235. Front Biosci (Elite Ed). 2011. PMID: 21196300 Free article.

9

[Endovascular placement of iodine-125 seed strand and self-expandable stent combined with transcatheter arterial chemoembolization for hepatocellular carcinoma with tumor thrombus in the main portal vein].

Luo JJ, Yan ZP, Wang JH, Liu QX, Qu XD, Zhang W. Luo JJ, et al. Zhonghua Zhong Liu Za Zhi. 2011 Jul;33(7):535-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22093634 Chinese.

10

Liver cancer: effects, safety, and cost-effectiveness of controlled-release oxycodone for pain control after TACE.

Zhou B, Wang J, Yan Z, Shi P, Kan Z. Zhou B, et al. Among authors: wang j. Radiology. 2012 Mar;262(3):1014-21. doi: 10.1148/radiol.11110552. Radiology. 2012. PMID: 22357901 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216,095 results

Search Page

Filters